Bio-Rad Laboratories, Inc. Class A Common Stock vs Liberty Global Ltd Class C — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Liberty Global Ltd Class C trades at $9.98 (market cap $3.48B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 2.7× Liberty Global Ltd Class C's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals.
| BIO | LBTYK | |
|---|---|---|
Market Cap | $9.43B | $3.48B |
Sector | Health | Technology |
52-Week High | $356.25 | $12.67 |
52-Week Low | $241.71 | $9.59 |
Enterprise Value | $9.18B | $10.13B |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →